Overview

Clinical Trial of Comparing DA-2902 and DA-2902-R in Healthy Adult Subjects

Status:
ENROLLING_BY_INVITATION
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This study is to compare pharmacokinetics and safety profiles of DA-2902 and DA-2902-R in healthy adult subjects
Phase:
PHASE1
Details
Lead Sponsor:
Dong-A ST Co., Ltd.